Call or Text Now! Available 24/7: 251-888-8888
Drug manufacturer, Hospira Inc., has issued a nationwide recall of four of its injectable cancer drugs due to glass particles that were embedded at the neck of the vial.
The recalled drugs include Carboplatin, Cytarabine, Paclitaxel and Methotrexate. They were distributed nationwide to both wholesalers and directly to customers.
According to the FDA, there is potential for the drugs to come in contact with the embedded glass particles and that the particles may become dislodged into the solutions.
Symptoms that a patient was injected with solutions mixed with the glass particles include:
The cause of the issue is attributed to a supplier glass defect. Hospira is arranging for the return and replacement of all recalled defective products.
Our Promise to Our Clients: You Won’t Pay a Dime Until We Win
That is why our team supports its clients at every step of the way. We handle almost every detail of your legal claims and make sure you have the information you need to make the best choice for your family and your future.